CS/BSE/NSE/PR/2016-2017

November 15, 2016

To
The Manager
Listing Department
National Stock Exchange of India Limited
Exchange Plaza, Bandra Kurla Complex
Bandra (E), Mumbai 400 051

To
The General Manager
Department of Corporate Services
BSE Limited
25th Floor, P. J. Towers,
Dalal Street, Mumbai - 400 001

Stock Code: SUVEN - EQ

Stock Code: 530239

Dear Sir/Madam,
Sub: Press Release

With reference to above subject, please find enclosed Press Release of our
company titled Suven Life Sciences is participating and presenting in Jefferies
London Healthcare Conference, London on Nov 16 and 17, 2016
This is for your information and records
Thanking You,
Yours faithfully,
For Suven Life Sciences Limited
K. Hanumantha Rao
Company Secretary

Suven Life Sciences Limited

Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7
Banjara Hills I Hyderabad 500 034 I Telangana I India I C IN : L 24 1 10 TG 1 98 9 P L C 00 9 7 1 3
Tel: 91 40 2354 1142/ 3311/ 3315 Fax: 91 40 2354 1152 Email: info@suven.com website: www.suven.com

News Release
HYDERABAD, INDIA (November 15, 2016): Suven Life Sciences is participating and
presenting in Jefferies London Healthcare Conference , London on Nov 16 and 17, 2016.
Jefferies London Healthcare Conference is the premier conference of its kind, bringing
together established industry leaders, emerging fast-growth companies, innovative
technology creators and globally minded service providers who will deliver presentations to
many investors across the globe.
Jefferies London Healthcare Conference is an investor and partnering conference devoted to
providing private and public biotechnology and life sciences companies with an opportunity
to present to, and meet with, investors and pharmaceutical executives in one place during
the course of one of the industry's largest annual healthcare investor conferences. Investors
and biopharmaceutical executives from around the world gather in London during this
critical week which is widely viewed as setting the tone for the coming year.
Mr. Venkat Jasti is scheduled to discuss the companys corporate overview, business
strategy and clinical development pipeline at Jefferies London Healthcare Conference where
the worlds top notch investment professionals will present along with the most innovative
companies who are decision makers.
Mr. Venkat Jasti and other members of the management team will be available for one-onone meetings at the conference. Members of the investment community who are interested
in meeting with management should contact Mr. Sunder Venkatraman, VP Corporate Affairs
of Suven at +1 732 718-9024 or vsunder@suven.com.
For more information please visit our Web site at http://www.suven.com
Risk Statement:
Except for historical information, all of the statements, expectations and assumptions, including
expectations and assumptions, contained in this news release may be forward-looking statements that
involve a number of risks and uncertainties. Although Suven attempts to be accurate in making these
forward-looking statements, it is possible that future circumstances might differ from the assumptions on
which such statements are based. Other important factors which could cause results to differ materially
including outsourcing trends, economic conditions, dependence on collaborative partnership programs,
retention of key personnel, technological advances and continued success in growth of sales that may make
our products/services offerings less competitive; Suven may not undertake to update any forward-looking
statements that may be made from time to time.

Suven Life Sciences Limited

Registered Office: 8-2-334 I SDE Serene Chambers I 6th FloorRoad No.5 I Avenue 7
Banjara Hills I Hyderabad 500 034 I Telangana I India I C IN : L 24 1 10 TG 1 98 9 P L C 00 9 7 1 3
Tel: 91 40 2354 1142/ 3311/ 3315 Fax: 91 40 2354 1152 Email: info@suven.com website: www.suven.com